US equities
|
MU
$896.07
▼-0.98%
NVDA
$216.47
▼-0.29%
SPCX
$147.79
▼-0.11%
AAPL
$339.50
▼-1.00%
TSLA
$373.71
▲+1.54%
META
$694.25
▼-1.59%
AMZN
$262.63
▲+0.07%
SNDK
$1,365.38
▼-0.42%
MU
$896.07
▼-0.98%
NVDA
$216.47
▼-0.29%
SPCX
$147.79
▼-0.11%
AAPL
$339.50
▼-1.00%
TSLA
$373.71
▲+1.54%
META
$694.25
▼-1.59%
AMZN
$262.63
▲+0.07%
SNDK
$1,365.38
▼-0.42%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by Cyteir Therapeutics, Inc.
Cyteir Therapeutics Reports First Quarter 2023 Financial Results and Operational Highlights
May 10, 2023
From
Cyteir Therapeutics, Inc.
Via
Business Wire
Tickers
CYT
Cyteir Therapeutics Announces Pricing of Initial Public Offering
June 17, 2021
From
Cyteir Therapeutics, Inc.
Via
Business Wire
Tickers
CYT